Cargando…

Licogliflozin, a Novel SGLT1 and 2 Inhibitor: Body Weight Effects in a Randomized Trial in Adults with Overweight or Obesity

OBJECTIVE: The aim of this study was to explore the dose response of licogliflozin, a dual inhibitor of sodium/glucose cotransporter 1 (SGLT1) and 2 (SGLT2), by evaluating change in body weight in adults with overweight or obesity. METHODS: This dose‐response analysis evaluated change in body weight...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bays, Harold E., Kozlovski, Plamen, Shao, Qing, Proot, Pieter, Keefe, Deborah
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7217021/ https://www.ncbi.nlm.nih.gov/pubmed/32187881 http://dx.doi.org/10.1002/oby.22764

Ejemplares similares

Effects of the dual sodium–glucose linked transporter inhibitor, licogliflozin vs placebo or empagliflozin in patients with type 2 diabetes and heart failure
por: de Boer, Rudolf A., et al.
Publicado: (2020)

Dose‐dependent reduction in body weight with LIK066 (licogliflozin) treatment in Japanese patients with obesity
por: Yokote, Koutaro, et al.
Publicado: (2020)

Sodium Glucose Co-transporter Type 2 (SGLT2) Inhibitors: Targeting the Kidney to Improve Glycemic Control in Diabetes Mellitus
por: Bays, Harold
Publicado: (2013)

Effects of Naltrexone Sustained- Release/Bupropion Sustained-Release Combination Therapy on Body Weight and Glycemic Parameters in Overweight and Obese Patients With Type 2 Diabetes
por: Hollander, Priscilla, et al.
Publicado: (2013)

Canagliflozin: Effects in overweight and obese subjects without diabetes mellitus
por: Bays, Harold E, et al.
Publicado: (2014)

Why does type 2 diabetes mellitus impair weight reduction in patients with obesity? A review
por: Bays, Harold Edward
Publicado: (2023)

Body Weight Gain and Hyperphagia After Administration of SGLT-2 Inhibitor: A Case Report
por: Hamamoto, Hiromi, et al.
Publicado: (2015)

Efficacy of Body Weight Reduction on the SGLT2 Inhibitor in People with Type 2 Diabetes Mellitus
por: Cho, Hyun A, et al.
Publicado: (2017)

Body weight gain and serum leptin levels of non-overweight and overweight/obese pregnant women
por: Filho, Didier Silveira Castellano, et al.
Publicado: (2013)

Obesity Pillars roundtable: Excessive weight reduction with highly effective anti-obesity medications (heAOMs)
por: Bays, Harold Edward, et al.
Publicado: (2022)

Emerging Role of SGLT-2 Inhibitors for the Treatment of Obesity
por: Pereira, Maria J., et al.
Publicado: (2019)

The effects of three weight management methods on body composition and serum lipids of overweight and obese people
por: Cai, Jingjing, et al.
Publicado: (2022)

Novel natural and synthetic inhibitors of solute carriers SGLT1 and SGLT2
por: Oranje, Paul, et al.
Publicado: (2019)

Body Weight Misperception and Dissatisfaction Among Overweight and Obese Adult Nigerians
por: Akindele, Mukadas Oyeniran, et al.
Publicado: (2017)

Cognitive insight is associated with perceived body weight in overweight and obese adults
por: Suliman, Sharain, et al.
Publicado: (2021)

Corrigendum: The effects of three weight management methods on body composition and serum lipids of overweight and obese people
por: Cai, Jingjing, et al.
Publicado: (2023)

Overweight, Obesity and Influence of Stress on Body Weight Among Undergraduate Medical Students
por: Gupta, Soma, et al.
Publicado: (2009)

Food-related behaviours among individuals with overweight/obesity and normal body weight
por: Brytek-Matera, Anna, et al.
Publicado: (2018)

Bone mineral density and body composition in normal weight, overweight and obese children
por: López-Peralta, Samantha, et al.
Publicado: (2022)

DPP-4 inhibitor treatment: β-cell response but not HbA(1c) reduction is dependent on the duration of diabetes
por: Kozlovski, Plamen, et al.
Publicado: (2017)

Prenatal Parental Separation and Body Weight, Including Development of Overweight and Obesity Later in Childhood
por: Hohwü, Lena, et al.
Publicado: (2015)

Body Satisfaction, Weight Stigma, Positivity, and Happiness among Spanish Adults with Overweight and Obesity
por: Godoy-Izquierdo, Débora, et al.
Publicado: (2020)

Effectiveness of Mobile Health Applications for 5% Body Weight Reduction in Obese and Overweight Adults
por: Han, Myeunghee, et al.
Publicado: (2021)

Prevalence of overweight and obesity among Kuwaiti adolescents and the perception of body weight by parents or friends
por: Al-Haifi, Ahmad R., et al.
Publicado: (2022)

Obesity Pillars Roundtable: Body mass index and body composition in Black and Female individuals. Race-relevant or racist? Sex-relevant or sexist?
por: Bays, Harold Edward, et al.
Publicado: (2022)

Adiposopathy, “Sick Fat,” Ockham’s Razor, and Resolution of the Obesity Paradox
por: Bays, Harold
Publicado: (2014)

Dieting practices, weight perceptions, and body composition: A comparison of normal weight, overweight, and obese college females
por: Malinauskas, Brenda M, et al.
Publicado: (2006)

The Role of SGLT2 Inhibitors in Vascular Aging
por: Liu, Le, et al.
Publicado: (2021)

Cancer and Obesity: An Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) 2022
por: Lazarus, Ethan, et al.
Publicado: (2022)

Dietary Intake and Physical Activity of Normal Weight and Overweight/Obese Adolescents
por: D'Addesa, Dina, et al.
Publicado: (2010)

Gut Microbiota Profile and Changes in Body Weight in Elderly Subjects with Overweight/Obesity and Metabolic Syndrome
por: Atzeni, Alessandro, et al.
Publicado: (2021)

Electrocardiographic changes associated with SGLT2 inhibitors and non-SGLT2 inhibitors: A multi-center retrospective study
por: Wu, Victor Chien-Chia, et al.
Publicado: (2022)

Sotagliflozin, a dual SGLT1 and SGLT2 inhibitor: In the heart of the problem
por: Vallianou, Natalia G., et al.
Publicado: (2021)

Dog attachment and perceived social support in overweight/obese and healthy weight children
por: Linder, Deborah E., et al.
Publicado: (2017)

Overweight and obesity: The efficacy of diets for weight maintenance after weight loss
por: Korczak, Dieter, et al.
Publicado: (2013)

Central obesity as a clinical marker of adiposopathy; increased visceral adiposity as a surrogate marker for global fat dysfunction
por: Bays, Harold
Publicado: (2014)

The Impact of Education on Weight Loss in Overweight and Obese Adults
por: Ostovan, Mohammad Ali, et al.
Publicado: (2013)

Genetic predictors of weight loss in overweight and obese subjects
por: Lamiquiz-Moneo, Itziar, et al.
Publicado: (2019)

Genetic Markers of Obesity Risk: Stronger Associations with Body Composition in Overweight Compared to Normal-Weight Children
por: Beyerlein, Andreas, et al.
Publicado: (2011)

Effect of glucomannan supplementation on body weight in overweight and obese children: protocol of a randomised controlled trial
por: Zalewski, Bartłomiej Mateusz, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_2k09vutr6dc0bdiosl8mie65ch